These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 8605148

  • 21. Interaction of Kazal-type inhibitor domains with serine proteinases: biochemical and structural studies.
    Schlott B, Wöhnert J, Icke C, Hartmann M, Ramachandran R, Gührs KH, Glusa E, Flemming J, Görlach M, Grosse F, Ohlenschläger O.
    J Mol Biol; 2002 Apr 26; 318(2):533-46. PubMed ID: 12051857
    [Abstract] [Full Text] [Related]

  • 22. Design of noncovalent trypsin inhibitor based on the X-ray crystal structure of the complex.
    Nakamura M, Tomoo K, Ishida T, Taguchi H, Tsuda Y, Okada Y, Okunomiya A, Wanaka K, Okamoto S.
    Biochem Biophys Res Commun; 1995 Aug 15; 213(2):583-7. PubMed ID: 7646515
    [Abstract] [Full Text] [Related]

  • 23. Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin.
    Baum B, Muley L, Heine A, Smolinski M, Hangauer D, Klebe G.
    J Mol Biol; 2009 Aug 21; 391(3):552-64. PubMed ID: 19520086
    [Abstract] [Full Text] [Related]

  • 24. Structure of the complex of trypsin with a highly potent synthetic inhibitor at 0.97 A resolution.
    Sherawat M, Kaur P, Perbandt M, Betzel C, Slusarchyk WA, Bisacchi GS, Chang C, Jacobson BL, Einspahr HM, Singh TP.
    Acta Crystallogr D Biol Crystallogr; 2007 Apr 21; 63(Pt 4):500-7. PubMed ID: 17372355
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The role of the insertion loop around tryptophan 148 in tthe activity of thrombin.
    DiBella EE, Scheraga HA.
    Biochemistry; 1996 Apr 09; 35(14):4427-33. PubMed ID: 8605192
    [Abstract] [Full Text] [Related]

  • 32. Nonpolar interactions of thrombin S' subsites with its bivalent inhibitor: methyl scan of the inhibitor linker.
    Slon-Usakiewicz JJ, Purisima E, Tsuda Y, Sulea T, Pedyczak A, Féthière J, Cygler M, Konishi Y.
    Biochemistry; 1997 Nov 04; 36(44):13494-502. PubMed ID: 9354617
    [Abstract] [Full Text] [Related]

  • 33. The crystal structures of human alpha-thrombin complexed with active site-directed diamino benzo[b]thiophene derivatives: a binding mode for a structurally novel class of inhibitors.
    Chirgadze NY, Sall DJ, Briggs SL, Clawson DK, Zhang M, Smith GF, Schevitz RW.
    Protein Sci; 2000 Jan 04; 9(1):29-36. PubMed ID: 10739244
    [Abstract] [Full Text] [Related]

  • 34. Multipolar interactions in the D pocket of thrombin: large differences between tricyclic imide and lactam inhibitors.
    Schweizer E, Hoffmann-Röder A, Olsen JA, Seiler P, Obst-Sander U, Wagner B, Kansy M, Banner DW, Diederich F.
    Org Biomol Chem; 2006 Jun 21; 4(12):2364-75. PubMed ID: 16763681
    [Abstract] [Full Text] [Related]

  • 35. Crystal structure of mung bean inhibitor lysine active fragment complex with bovine beta-trypsin at 1.8A resolution.
    Zhu Y, Huang Q, Chi C.
    J Biomol Struct Dyn; 1999 Jun 21; 16(6):1219-24. PubMed ID: 10447205
    [Abstract] [Full Text] [Related]

  • 36. The crystal structure of human alpha-thrombin complexed with LY178550, a nonpeptidyl, active site-directed inhibitor.
    Chirgadze NY, Sall DJ, Klimkowski VJ, Clawson DK, Briggs SL, Hermann R, Smith GF, Gifford-Moore DS, Wery JP.
    Protein Sci; 1997 Jul 21; 6(7):1412-7. PubMed ID: 9232642
    [Abstract] [Full Text] [Related]

  • 37. The crystal structure of alpha-thrombin-hirunorm IV complex reveals a novel specificity site recognition mode.
    Lombardi A, De Simone G, Nastri F, Galdiero S, Della Morte R, Staiano N, Pedone C, Bolognesi M, Pavone V.
    Protein Sci; 1999 Jan 21; 8(1):91-5. PubMed ID: 10210187
    [Abstract] [Full Text] [Related]

  • 38. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
    Koepke J, Ermler U, Warkentin E, Wenzl G, Flecker P.
    J Mol Biol; 2000 May 05; 298(3):477-91. PubMed ID: 10772864
    [Abstract] [Full Text] [Related]

  • 39. Predicted three-dimensional structural models of venom serine protease inhibitors and their interactions with trypsin and chymotrypsin.
    Azim MK, Grossmann JG, Zaidi ZH.
    J Nat Toxins; 1999 Oct 05; 8(3):363-84. PubMed ID: 10591040
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.